Skip to content

Identification of Multimorbid Patients With a Higher Probability of Readmission and Mortality

Identification of Multimorbid Patients With a Higher Probability of Readmission and Mortality: Role of Patient-related Variables

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05574790
Enrollment
500
Registered
2022-10-12
Start date
2022-02-07
Completion date
2023-08-30
Last updated
2023-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multimorbidity

Keywords

multimorbid Patients, Readmission, Mortality, Predictive

Brief summary

A prospective qualitative quantitative study was designed to create predictive models of readmission in multimorbid patients.

Detailed description

Social determinants have been shown to be related to the probability of readmission and death in multimorbid patients. These are increasingly older, which makes them more likely to be readmitted when their preferences are usually to be at home. Objective: To create and validate prediction models for readmission and mortality during home transitional period (1 month) and up to a year, in multimorbid patients, including variables related to the patient and their social environment. Design: Quali-quantitative. 4 hospitals from 3 regions (Andalucia, Catalonia and the Basque Country) will participate . Patients presenting at least 2 of the Ollero's categories will be included. Variables will be identified by means of nominal groups of professionals and focal groups with patients and caregivers. These variables will be included in the final models join to clinical variables, PROMS (health related quality of life, burden of the caregiver , social support). Logistic/ Cox regression models will be developed and validated internally to identify the risk of readmission and death which will be validated in an external cohort. Expected results: We hope to provide the health system with stratification tools for polypathological patients that help in identifying those patients with the greatest need for individualized interventions.

Interventions

OTHERannual follow up

Collection of the following information during the year following discharge from the initial episode (initial cohort): readmissions, dates and causes of readmission, mortality

Sponsors

Hospital Costa del Sol
CollaboratorOTHER
Hospital del Mar
CollaboratorOTHER
Instituto de Salud Carlos III
CollaboratorOTHER_GOV
Hospitales Universitarios Virgen del Rocío
CollaboratorOTHER
Asociacion Instituto de Investigacion en Servicios de Salud Kronikgune
CollaboratorUNKNOWN
Hospital Galdakao-Usansolo
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over 18 years of age * Patients discharged from the Internal Medicine departments of the participating centers due to acute pathology, de novo or decompensation of a chronic pathology who also present at least 2 of the cathegories of Ollero et al.

Exclusion criteria

* Patients admitted for end-of-life treatment, scheduled admissions, exacerbation of rheumatic pathology or systemic disease, study of anaemia in patients with no-known comorbidity, search for neoplasia and acute processes without associated comorbidity. - * Failure to sign the informed consent form.

Design outcomes

Primary

MeasureTime frameDescription
Readmission1 monthnumber of readmissions in the early period (transition to discharge, 1 month

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026